本レポートは、力強い成長を経験している肺動脈高血圧症市場に焦点を当てています。本 レポートは、今後10年以上にわたって私たちの生活を形作り変化させる肺動脈高血圧症市場へのガイドを提供します。
目次
Table of Contents
1. Executive Summary
2. Pulmonary Arterial Hypertension Market Characteristics
3. Pulmonary Arterial Hypertension Market Trends And Strategies
4. Pulmonary Arterial Hypertension Market - Macro Economic Scenario
4.1 COVID-19 Impact On Pulmonary Arterial Hypertension Market
4.2 Ukraine-Russia War Impact On Pulmonary Arterial Hypertension Market
4.3 Impact Of High Inflation On Pulmonary Arterial Hypertension Market
5. Pulmonary Arterial Hypertension Market Size And Growth
5.1. Global Pulmonary Arterial Hypertension Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Pulmonary Arterial Hypertension Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Pulmonary Arterial Hypertension Market Segmentation
6.1. Global Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Endothelin Receptor Antagonists (ERAs)
PDE-5 Inhibitors
Prostacyclin and Prostacyclin Analogs
SGC Stimulators
6.2. Global Pulmonary Arterial Hypertension Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Oral
Intravenous/ subcutaneous
Inhalational
6.3. Global Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Retail
Online
7. Pulmonary Arterial Hypertension Market Regional And Country Analysis
7.1. Global Pulmonary Arterial Hypertension Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Pulmonary Arterial Hypertension Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Pulmonary Arterial Hypertension Market
8.1. Asia-Pacific Pulmonary Arterial Hypertension Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Pulmonary Arterial Hypertension Market
9.1. China Pulmonary Arterial Hypertension Market Overview
9.2. China Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Pulmonary Arterial Hypertension Market
10.1. India Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Pulmonary Arterial Hypertension Market
11.1. Japan Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Pulmonary Arterial Hypertension Market
12.1. Australia Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Pulmonary Arterial Hypertension Market
13.1. Indonesia Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Pulmonary Arterial Hypertension Market
14.1. South Korea Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Pulmonary Arterial Hypertension Market
15.1. Western Europe Pulmonary Arterial Hypertension Market Overview
15.2. Western Europe Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Pulmonary Arterial Hypertension Market
16.1. UK Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Pulmonary Arterial Hypertension Market
17.1. Germany Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Pulmonary Arterial Hypertension Market
18.1. France Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Pulmonary Arterial Hypertension Market
19.1. Eastern Europe Pulmonary Arterial Hypertension Market Overview
19.2. Eastern Europe Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Pulmonary Arterial Hypertension Market
20.1. Russia Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Pulmonary Arterial Hypertension Market
21.1. North America Pulmonary Arterial Hypertension Market Overview
21.2. North America Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Pulmonary Arterial Hypertension Market
22.1. USA Pulmonary Arterial Hypertension Market Overview
22.2. USA Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Pulmonary Arterial Hypertension Market
23.1. South America Pulmonary Arterial Hypertension Market Overview
23.2. South America Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Pulmonary Arterial Hypertension Market
24.1. Brazil Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Pulmonary Arterial Hypertension Market
25.1. Middle East Pulmonary Arterial Hypertension Market Overview
25.2. Middle East Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Pulmonary Arterial Hypertension Market
26.1. Africa Pulmonary Arterial Hypertension Market Overview
26.2. Africa Pulmonary Arterial Hypertension Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Pulmonary Arterial Hypertension Market, Segmentation By Distribution channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Pulmonary Arterial Hypertension Market Competitive Landscape And Company Profiles
27.1. Pulmonary Arterial Hypertension Market Competitive Landscape
27.2. Pulmonary Arterial Hypertension Market Company Profiles
27.2.1. United Therapeutics Corporation
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Bayer AG
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Gilead Sciences Inc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Johnson & Johnson
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. GlaxoSmithKline
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Pulmonary Arterial Hypertension Market
29. Pulmonary Arterial Hypertension Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer
